Demystifying Staging in Cancer: How Tumors are Classified

Staging is the cornerstone of oncological care. It dictates the treatment protocol, estimates prognosis, and provides a universal language for multidisciplinary tumor boards. The most widely accepted system globally is the TNM classification.

The TNM Classification System

Developed by the AJCC and UICC, the TNM system evaluates three primary criteria to determine the extent of the disease:

Translating TNM into Stages (I-IV)

Once TNM parameters are established, the cancer is assigned an overall stage. Stage I generally indicates a small, localized tumor. Stages II and III denote larger tumors with potential lymph node involvement. Stage IV (Metastatic) signifies that the disease has spread to other parts of the body.

Accurate staging often requires a combination of imaging (PET/CT, MRI), endoscopic procedures, and surgical biopsies. Precision in staging prevents both under-treatment (risking recurrence) and over-treatment (causing unnecessary toxicity).